Thomas John Dietz's Net Worth
-$175 Thousand
Who is Thomas John Dietz?
Thomas John Dietz does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include LEAP THERAPEUTICS, INC., Eiger BioPharmaceuticals, Inc., and Transcept Pharmaceuticals Inc.
SEC CIK
Thomas John Dietz's CIK is 0001574218
Past Insider Trading and Trends
2020 was Thomas John Dietz's most active year for acquiring shares with 9 total transactions. Thomas John Dietz's most active month to acquire stocks was the month of February. 2023 was Thomas John Dietz's most active year for disposing of shares, totalling 9 transactions. Thomas John Dietz's most active month to dispose stocks was the month of August. 2018 saw Thomas John Dietz paying a total of $106,200.00 for 43,750 shares, this is the most they've acquired in one year. In 2018 Thomas John Dietz cashed out on 11,430 shares for a total of $76,605.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LEAP THERAPEUTICS, INC. (LPTX) Snapshot price: $2.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eiger BioPharmaceuticals, Inc. (EIGR) No price found
InvestorThomas John Dietz owns 21,000 units of Common Stock. In the year 2016 Thomas John Dietz filed a total of 19 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 50K |
$1.43 | $71,580.00 | 50K |
Jan 23
| |||
Form 4
| -51.72% | -22.50K |
$1.17 | -$26,302.50 | 21K |
Dec 22
| |||
Form 4
| +16.00% | 6K |
—
|
—
| 43.5K |
Mar 11
| |||
Form 4
| +7.14% | 2.5K |
$8.49 | $21,220.00 | 37.5K |
Apr 9
| |||
Form 4
| +16.67% | 5K |
—
|
—
| 35K |
Mar 12
| |||
Form 4
| +3.45% | 1K |
$4.95 | $4,950.00 | 30K |
Mar 16
| |||
Form 4
| +20.83% | 5K |
—
|
—
| 29K |
Mar 12
| |||
Form 4
| +20.00% | 4K |
$13.94 | $55,760.00 | 24K |
Jan 10
| |||
Form 4
| +33.33% | 5K |
$11.10 | $55,495.00 | 20K |
Apr 23
| |||
Form 4
| +50.00% | 5K |
$11.05 | $55,250.00 | 15K |
Apr 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| +100.00% | 5K |
$9.98 | $49,900.00 | 10K |
Dec 20
| |||
Form 4
|
∞
| 5K |
$11.26 | $56,300.00 | 5K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Transcept Pharmaceuticals Inc No price found
InvestorThomas John Dietz used to own units in Common Stock but no longer holds any shares there. In the year 2013 Thomas John Dietz filed a total of 17 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -69.25K |
—
|
—
|
0
|
Sep 21
| |||
Form 4
| +40.00% | 20K |
—
|
—
| 70K |
Feb 8
| |||
Form 4
| +66.67% | 20K |
—
|
—
| 50K |
Feb 16
| |||
Form 4
| +42.86% | 9K |
—
|
—
| 30K |
Feb 18
| |||
Form 4
| +75.00% | 9K |
—
|
—
| 21K |
Feb 19
| |||
Form 4
| +166.67% | 7.5K |
—
|
—
| 12K |
Feb 26
| |||
Form 4
| -40.00% | -3.00K |
$7.14 | -$21,420.00 | 4.5K |
Scheduled
|
Feb 15
| ||
Form 4
| -55.44% | -9.33K |
$5.01 | -$46,743.30 | 7.5K |
Dec 21
| |||
Form 4
| +80.39% | 7.5K |
—
|
—
| 16.83K |
Feb 14
| |||
Form 4
| -18.37% | -2.10K |
$14.22 | -$29,862.00 | 9.33K |
Scheduled
|
Feb 5
| ||
Form 4
| +110.50% | 6K |
—
|
—
| 11.43K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
∞
| 5.43K |
—
|
—
| 5.43K |
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||